San Diego Clinic
- PRP Therapy
- Ozone Therapy
- IV Therapy
- Arthritis Treatment
- Chelation Therapy
La Jolla, CA
Chelation Therapy clinics in La Jolla
Chelation therapy in La Jolla is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity confirmed by provocation or baseline testing. Common agents include calcium disodium EDTA, DMPS, DMSA, and deferoxamine, each with specific binding profiles for lead, mercury, arsenic, or iron.
Most La Jolla chelation providers are MDs or DOs with ACAM training, and in some states naturopathic doctors within their licensed scope. Protocols vary from 10-session courses for basic detoxification to longer 30-session cardiovascular protocols modeled on the TACT trial. Pricing is cash-pay in almost every case, and no insurance covers off-label chelation.
With verified chelation therapy clinics on Regenerated.com in La Jolla, California, patients can compare provider credentials, testing protocols, and agent selection. Regenerated.com does not recommend chelation for cardiovascular disease or autism. The FDA has only approved specific agents for specific heavy metal poisoning diagnoses. Chelation outside that narrow indication is off-label, and in the wrong hands it has caused deaths.
Moss Center for Integrative Medicine
- Vitamin IV Therapy
- IV Therapy
- Arthritis Treatment
- Chelation Therapy
- Migraine Treatment
MD on staff
San Diego Center for Restorative Medicine
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Shockwave Therapy
Integrative Health Solutions
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- IV Hydration
MD on staff
Kadima Neuropsychiatry Institute
- Ozone Therapy
- IV Therapy
- Transcranial Magnetic Stimulation (TMS)
- Hyperbaric Oxygen Therapy (HBOT)
- Ketamine Therapy
Create Wellness, Dr. Roya Nikzad
- Vitamin IV Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Chelation Therapy
Regulatory context
A note on California's chelation therapy rules.
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
-
California Medical Practice Act, Business and Professions Code Section 2052
Only physicians licensed by the Medical Board of California may diagnose and treat, including prescribing chelating agents. -
California Naturopathic Doctors Act, Business and Professions Code Section 3613
California-licensed NDs have a defined scope that includes some IV therapies under physician supervision.
The Medical Board of California has disciplined physicians for marketing chelation as a treatment for autism, atherosclerosis, and Alzheimer's disease without adequate informed consent or evidence base. California Department of Public Health has investigated clinics for unsanitary IV practices. The Pittsburgh 2005 pediatric autism chelation death prompted California medical board guidance reinforcing that the wrong EDTA salt (Na2EDTA versus CaNa2EDTA) can be fatal. Compounded DMPS distribution has drawn scrutiny under California pharmacy law.